Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Conducted at Samsung Medical Center, the Phase 3 clinical trial enrolled 24 newly diagnosed Hunter Syndrome patients with no prior treatment. It evaluated the efficacy and safety of Hunterase over a ...

Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device ...

Black patients admitted to the hospital for labor and delivery are more likely to have stigmatizing language documented in their clinical notes than White patients, Columbia University School of ...

Abbreviated breast MRI shortens exam time while retaining a high level of diagnostic accuracy of breast cancer in women with extremely dense breasts, according to an article published today in ...

HeartcoR Solutions, a leading ECG core lab that conducts cardiac safety studies for the pharmaceutical, medical device, and CRO industries, announced today that it has partnered with Wellysis, a ...

Emergency department nurses and patients at Adventist HealthCare hospitals are getting extra support and a second opinion during the triage process with the help of artificial intelligence. The ...

Paragonix Technologies, a leader in organ transplant technologies and services, today announced the successful completion of its hundredth case using the FDA-cleared KidneyVault ™ Portable Renal ...

In this role, Dr Martin Hepburn will drive Panther’s strategic commitment to commercialize its patented MAP technology, with a primary focus on reducing time-to-market and delivering the first ...

TekniPlex, a global leader of innovative solutions through materials science expertise, has named long-tenured senior executive Suj Mehta as CEO of its Healthcare Division. Mr. Mehta assumes permanent ...

The Wyss Center has granted BrainScape Medical an exclusive license for Epios®, a cutting-edge platform designed for continuous, long-term brain activity monitoring. Epios® offers a minimally invasive ...

Fore Genomics, a leader in pediatric genetic health screening, announced a strategic partnership with Inocras, a leading innovator in whole genome sequencing (WGS) and AI-powered genetic analysis ...